Immunogenicity of clinically relevant SARS-CoV-2 vaccines in nonhuman primates and humans

Multiple preventive vaccines are being developed to counter the coronavirus disease 2019 pandemic. The leading candidates have now been evaluated in nonhuman primates (NHPs) and human phase 1 and/or phase 2 clinical trials. Several vaccines have already advanced into phase 3 efficacy trials, while o...

Descripción completa

Detalles Bibliográficos
Autores principales: Klasse, P. J., Nixon, Douglas F., Moore, John P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for the Advancement of Science 2021
Materias:
Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7978427/
https://www.ncbi.nlm.nih.gov/pubmed/33608249
http://dx.doi.org/10.1126/sciadv.abe8065

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7978427/
https://www.ncbi.nlm.nih.gov/pubmed/33608249
http://dx.doi.org/10.1126/sciadv.abe8065

Ejemplares similares